<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00733564</url>
  </required_header>
  <id_info>
    <org_study_id>NMU-FY2008-209</org_study_id>
    <secondary_id>NJFY0890-MZ12</secondary_id>
    <nct_id>NCT00733564</nct_id>
  </id_info>
  <brief_title>Evaluation of Different Anesthesia for Uterine Curettage</brief_title>
  <acronym>EDAUC</acronym>
  <official_title>Evaluation of the Anesthetic Efficacy of Propofol,Sevoflurane and Paracervical Block for Uterine Curettage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anesthesia during uterine curettage is a problem. Paracervical block is used in general for
      such an operation, though, the anesthetic efficacy is incomplete. Propofol is the
      short-lasting intravenous anesthetic administrated popularly. Sevoflurane is a new
      inhalational anesthetic well-known for it's &quot;easy come, easy go&quot; property. The investigators
      hypothesized that propofol, sevoflurane and paracervical block had different anesthetic
      efficacy during uterine curettage. Which one is the optimal selection for such operation
      needed to be evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bispectral Index (BIS) value</measure>
    <time_frame>0, 5, 10, 20, 30min after anesthesia</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraoperative awareness</measure>
    <time_frame>0, 5, 10, 20, 30min after anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital signs</measure>
    <time_frame>0, 5, 10, 15, 20, 25, 30min after anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial blood gas analysis</measure>
    <time_frame>5min before operation; 1min and 5min after beginning of the operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>0, 5, 10, 20, 30min after surgical procedures</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cortisol level</measure>
    <time_frame>30min before operation; 1 and 5min during operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>30min after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uterine bleeding</measure>
    <time_frame>0min after completion of the operation; 1 hour after the operation</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Uterine Curettage</condition>
  <condition>Abortion, Induced</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Paracervical block will be performed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propofol anesthesia will be performed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sevoflurane anesthesia will be performed</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>Paracervical injection of 2% Lidocaine to block associated nociception input</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Lignocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol 3mg/kg will be injected intravenously; 1 mg/kg will be added additionally for incomplete anesthesia</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Diprivan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Sevoflurane 8% for anesthesia induction, 2-3% as the maintenance</description>
    <arm_group_label>3</arm_group_label>
    <other_name>Sevorane</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA status I-II

          -  Performing abortion operation (medical- or surgical)

          -  Requiring painless abortion

        Exclusion Criteria:

          -  &lt; 19 yrs, and &gt;=45 yrs

          -  History of central active drugs administration

          -  Drug abuse

          -  Hypertension

          -  Diabetes

          -  Any other chronic diseases

          -  Allergy to the study drugs

          -  Habit of over-volume alcohol drinking

          -  Records of history of centrally active drug use and psychiatry

          -  Any organic disorder
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>XiaoFeng Shen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Nanjing Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nanjing Maternal and Child Health Care Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2008</study_first_submitted>
  <study_first_submitted_qc>August 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2008</study_first_posted>
  <last_update_submitted>March 30, 2009</last_update_submitted>
  <last_update_submitted_qc>March 30, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 31, 2009</last_update_posted>
  <responsible_party>
    <name_title>XiaoFeng Shen</name_title>
    <organization>Nanjing Medical University</organization>
  </responsible_party>
  <keyword>Local anesthetic</keyword>
  <keyword>Propofol</keyword>
  <keyword>Sevoflurane</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

